David Miller on LinkedIn: #omicron #TMA #COVID19
The #omicron variant has been described by some as “mild,” but physicians urge Texans not to let their guard down. #TMA #COVID19 Task Force member John…
The #omicron variant has been described by some as “mild,” but physicians urge Texans not to let their guard down. #TMA #COVID19 Task Force member John…
From protocol development to timely recruitment and retention to regulatory approval, it is crucial that trial subjects feel involved, retain their autonomy…
A few days ago, I was reading “Brandsplaining”, a book that made my brain churn tons of thoughts. And I cannot help but share those…
👀 𝗖𝘂𝗿𝗶𝗼𝘂𝘀 𝗮𝗯𝗼𝘂𝘁 𝘁𝗵𝗲 𝗲𝘃𝗼𝗹𝘃𝗶𝗻𝗴 𝗹𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲 𝗼𝗳 𝗟𝗟𝗠𝘀 𝗮𝗻𝗱 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺 𝗽𝗿𝗼𝘃𝗶𝗱𝗲𝗿𝘀? It’s been a whirlwind since… | 10 comments on LinkedIn
Eric Herzog, CMO at Infinidat “As we recognize World Backup Day 2024, the industry needs to acknowledge backup has dramatically changed so much that new…
Join us for a symposium on ulcerative colitis (UC) designed to encourage the exchange of ideas between leaders in the field and attendees. This event…
Join us for an exciting discussion where expert oncologists in the field of colorectal cancer will deliberate on nuances related to sequencing oral tyrosine kinase…
1. For patients with localized endometrial cancer recurrence, adding cisplatin to radiation therapy did not appear to improve progression-free survival when compared to radiation therapy…
One of the most exciting parts of my job is brainstorming with forward-thinking physicians across multiple specialties and industries. Leveraging digital technologies like augmented reality,…
A scientific paper given its matter-of-fact tonality, evidence-backed claims, sacrosanct templates, and peer-reviewed validations has no room for impassioned storytelling. Having said that, much about…
What a month of urology excitement April has been! It was wonderful to see over 10,000 urologists join us in Paris at EAU24. All with…